Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
kabonk's Profile
Displaying 1-50 of 238 result(s).
CYDY CytoDyn Inc
05/07/2025 10:35:48 AM
Thanks. You're the best. I forgot a (11)
CYDY CytoDyn Inc
05/06/2025 11:44:03 PM
Not sure if they ever disclosed rec (5)
CYDY CytoDyn Inc
05/05/2025 2:28:23 PM
CCR5 bound by leronlimab would have (5)
CYDY CytoDyn Inc
08/20/2024 3:41:55 PM
Agree, there is lots of jibberish o (8)
CYDY CytoDyn Inc
08/13/2024 4:52:30 PM
Agree with you that the primary end (15)
CYDY CytoDyn Inc
08/13/2024 1:33:54 PM
Q: Are we hoping to improve upon th (11)
CYDY CytoDyn Inc
06/04/2024 12:08:14 PM
No, VIR is developing broadly neutr (7)
CYDY CytoDyn Inc
05/16/2024 3:07:46 PM
Ha, good questions and observations (1)
CYDY CytoDyn Inc
05/16/2024 2:34:44 PM
I wondered the same (new priority o (4)
CYDY CytoDyn Inc
05/16/2024 1:39:46 PM
Good to see some progress on trial (4)
CYDY CytoDyn Inc
05/15/2023 3:02:38 PM
It's nice that pubmed links to the (2)
CYDY CytoDyn Inc
05/15/2023 2:09:25 PM
Except the mice with disabled CCR5 (5)
CYDY CytoDyn Inc
12/19/2022 4:10:16 PM
Stiff person's syndrome neurodiagno (5)
CYDY CytoDyn Inc
12/14/2022 11:14:13 PM
Lipid nanoparticles encapsulation l (4)
CYDY CytoDyn Inc
12/14/2022 4:19:42 PM
Only problem with AAV transgene pro (9)
CYDY CytoDyn Inc
10/28/2022 10:36:32 PM
HIV patients with NASH is an area o
CYDY CytoDyn Inc
08/08/2022 10:59:26 PM
Hahaha, a rhetorical question. For (1)
CYDY CytoDyn Inc
08/03/2022 9:06:33 AM
Sorry .. can't edit on phone .. thi
CYDY CytoDyn Inc
08/03/2022 9:00:54 AM
I think the Sasha grant was a Cente
CYDY CytoDyn Inc
07/27/2022 6:25:59 PM
Nice writeup. In the news recently (7)
CYDY CytoDyn Inc
07/11/2022 12:25:58 PM
This will be in monkeys, like Sacha (6)
CYDY CytoDyn Inc
07/05/2022 5:37:52 PM
Yes I think they have already had s (1)
CYDY CytoDyn Inc
07/05/2022 8:08:07 AM
Unfortunately, AAV is not currently (4)
CYDY CytoDyn Inc
07/05/2022 12:44:26 AM
No, only one daughter cell would ge (3)
CYDY CytoDyn Inc
05/13/2022 2:37:48 PM
FDA is another corrupt failed burea (3)
CYDY CytoDyn Inc
04/01/2022 1:57:30 PM
The reason for the clinical hold wa (2)
CYDY CytoDyn Inc
03/31/2022 9:08:19 PM
Nice .. 7 years of safe monotherapy (3)
CYDY CytoDyn Inc
02/28/2022 4:27:24 PM
Well, the analysis probably is wron (6)
CYDY CytoDyn Inc
02/28/2022 2:32:57 PM
Great question, and it's too bad th (8)
CYDY CytoDyn Inc
02/17/2022 5:46:12 PM
Dark matter is not repulsive. Not s (1)
CYDY CytoDyn Inc
02/17/2022 5:27:41 PM
For the record, Rathke admitted to (1)
CYDY CytoDyn Inc
02/17/2022 4:49:29 PM
No, take a closer look at it. Take (3)
CYDY CytoDyn Inc
02/17/2022 3:53:32 PM
Forever is a very long time for a s (4)
CYDY CytoDyn Inc
02/17/2022 3:42:20 PM
Another review article from that si (5)
CYDY CytoDyn Inc
02/16/2022 1:01:19 PM
There are some long lived memory T- (1)
CYDY CytoDyn Inc
02/15/2022 2:38:37 PM
Patterson recently posted prelimina (7)
CYDY CytoDyn Inc
02/14/2022 12:00:41 PM
Nice review of chemokine signaling (6)
CYDY CytoDyn Inc
02/02/2022 12:37:39 PM
Lots of options/possibilities for f
CYDY CytoDyn Inc
02/02/2022 12:08:16 PM
I wonder if this financing is someh
CYDY CytoDyn Inc
01/31/2022 4:40:40 PM
They stopped recruiting for all the (8)
CYDY CytoDyn Inc
01/28/2022 2:11:50 PM
Which part do you take as speculati (1)
CYDY CytoDyn Inc
01/28/2022 1:46:28 PM
The 11/27/22 8-K says (b) On Januar (3)
CYDY CytoDyn Inc
01/28/2022 12:43:33 PM
Thanks for pulling this out. One ve (1)
CYDY CytoDyn Inc
01/26/2022 9:43:41 PM
Bingo: Its possible that the cytoki (4)
CYDY CytoDyn Inc
01/25/2022 11:33:51 AM
Several other therapies that work . (2)
CYDY CytoDyn Inc
01/20/2022 11:24:12 AM
Canceled CC, waiting for updates on (5)
CYDY CytoDyn Inc
01/15/2022 1:57:59 PM
Cash bond is because Amarex claims (3)
CYDY CytoDyn Inc
01/12/2022 1:15:58 PM
Nice article. Agree that Omicron in (7)
CYDY CytoDyn Inc
01/11/2022 11:31:08 AM
Unfortunately, 10-Q page 35 says: I (4)
CYDY CytoDyn Inc
01/10/2022 11:40:15 AM
Regnum is now run by Anne Kirby, fo (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Auburn National Bancorporation Sees Income Growth in Q3
  • Ingersoll Rand Announces Quarterly Cash Dividend Increase
  • Boston Scientific Reports Strong Q3 Earnings Amid Challenges
  • LanzaTech's Strategic Moves to Propel Sustainable Aviation Fuel Forward
  • Boston Beer Company Delivers Strong Q3 Results Amid Challenges
  • Texxon Holding Limited Completes Successful $9.5 Million IPO
  • Elme Communities Reveals Financial Insights for Q3 2025
  • Phillips Edison & Company Reports Strong Growth for 2025
  • Mohawk Industries: Unveiling Q3 Financial Performance Insights
  • First Western's Q3 2025 Financial Results Showcase Strength
  • Qualigen Therapeutics and BitGo Enhance Corporate Treasury Strategy
  • Celebrating Lights On Afterschool: Engaging Communities Nationwide
  • Innovative Approach to Digital Banking with U.S. Dollar Tokenization
  • Elme Communities Reveals Q3 2025 Financial Performance Insights
  • NAV CANADA Reports Strong Financial Performance for 2025
  • First Western Sees Significant Growth in Q3 Financials
  • Mohawk Industries Shows Resilience in Q3 Earnings Report
  • Exciting Updates from BorgWarner's Upcoming Conference Call
  • Turtle Beach to Share Q3 Financial Results and Insights Soon
  • Definitive Healthcare to Host Q3 2025 Results Conference Call
  • IBEX Limited Plans Exciting Financial Release Event Soon
  • Elutia Set to Reveal Third Quarter Results Soon
  • Enova International Achieves Record Growth in Q3 2025
  • Boston Beer Company Releases Insightful Q3 Financial Results
  • Epsilon Energy Ltd. Announces Third Quarter Earnings Call
  • Federated Hermes Expands Reach Through Strategic Acquisition
  • Ellomay Capital's AGM Outcome and Future Growth Plans
  • Baker Hughes Announces Exciting New Quarterly Dividend Details
  • Supporting Veterans: Elevate Holistics and Medical Cannabis Access
  • Itron Inc. Sets Stage for Upcoming Investor Engagements
  • H&R Block Announces Upcoming Fiscal 2026 Quarter Results
  • HeartFlow Innovates with Upcoming Q3 Financial Release
  • Pheton Holdings Addresses Nasdaq Bid Price Compliance Challenges
  • Halper Sadeh LLC Urges Shareholders of HSII and VMEO to Act Now
  • Upcoming Conference Call Discusses Nature's Sunshine Growth
  • Clarus Corporation's Upcoming Third Quarter Financial Update
  • BlackLine Sets Date for Q3 2025 Earnings Announcement
  • Highwoods Properties Announces Significant Dividend Payments
  • Archrock Shares Exciting News on Cash Dividend and Growth
  • Treace Medical Concepts Set to Announce Q3 Financial Results
  • Nicolet Bankshares Merges with MidWestOne Financial Group
  • Dynagas LNG Partners Announces Preferred Unit Distribution
  • Definitive Healthcare's Upcoming Third Quarter Earnings Call Details
  • Iovance Biotherapeutics Announces Q3 2025 Webcast Details
  • Flywire Ignites Financial Agility at Client Conference
  • Arteris, Inc. Prepares to Share Q3 Financial Results Soon
  • Farmer Brothers Coffee Set to Release Q1 2026 Financial Results
  • Wintrust Financial Announces New Quarterly Cash Dividend Policy
  • Leadership Change at Teladoc Health: CFO Transition Launched
  • Teads Holding Co. Plans Financial Results Release in November
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site